|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0035435,
umls-concept:C0087111,
umls-concept:C0102118,
umls-concept:C0243127,
umls-concept:C0262950,
umls-concept:C0333348,
umls-concept:C0392747,
umls-concept:C0439828,
umls-concept:C0443172,
umls-concept:C0443331,
umls-concept:C1521725,
umls-concept:C2745888
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-8-15
|
|
pubmed:abstractText |
Alendronate treatment for 12 months in pediatric patients with rheumatic diseases and secondary low bone mass was reported to result in a substantial increase in bone mineral density (BMD). In this study, we evaluated the changes in bone metabolism and disease activity markers in 45 patients ages 5 to 18 years (31 female, 14 male) with rheumatic diseases treated with alendronate for 12 months.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
pubmed-author:BardareMariaM,
pubmed-author:BianchiMaria LuisaML,
pubmed-author:ChiesaSabrinaS,
pubmed-author:CimazRolandoR,
pubmed-author:CoronaFabriziaF,
pubmed-author:DubiniAntonellaA,
pubmed-author:FalciniFernandaF,
pubmed-author:GattornoMarcoM,
pubmed-author:LenhardtAlessandroA,
pubmed-author:LeporeLoredanaL,
pubmed-author:MartiniGiorgiaG,
pubmed-author:MasiLauraL,
pubmed-author:SormaniMaria PiaMP,
pubmed-author:ZulianFrancescoF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1786-92
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12180745-Adolescent,
pubmed-meshheading:12180745-Alendronate,
pubmed-meshheading:12180745-Anthropometry,
pubmed-meshheading:12180745-Biological Markers,
pubmed-meshheading:12180745-Bone Density,
pubmed-meshheading:12180745-Bone Resorption,
pubmed-meshheading:12180745-Child,
pubmed-meshheading:12180745-Child, Preschool,
pubmed-meshheading:12180745-Female,
pubmed-meshheading:12180745-Humans,
pubmed-meshheading:12180745-Lumbar Vertebrae,
pubmed-meshheading:12180745-Male,
pubmed-meshheading:12180745-Rheumatic Diseases
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases.
|
|
pubmed:affiliation |
Clinica Pediatrica, ICP, Milano, Italy. rolando.cimaz@unimi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
